||
提高免疫检查点抑制剂的抗肿瘤反应和减少副作用https://www.ebiotrade.com/newsf/2023-6/20230601090912709.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=42c6875b-bcf9-49f8-a574-f454c436cdc5
01. | Humans | 33 篇 | 78.571% |
02. | Animals | 22 篇 | 52.381% |
03. | Neoplasms | 18 篇 | 42.857% |
04. | Immunotherapy | 17 篇 | 40.476% |
05. | Immune Checkpoint Inhibitors | 15 篇 | 35.714% |
06. | Mice | 12 篇 | 28.571% |
07. | Female | 10 篇 | 23.810% |
08. | Programmed Cell Death 1 Receptor | 10 篇 | 23.810% |
09. | Tumor Microenvironment | 9 篇 | 21.429% |
10. | B7-H1 Antigen | 8 篇 | 19.048% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2023-10-4 21:04
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社